Skip to content

Medial Tibial Stress Syndrome Prevention

Efficacy of a Lower Leg Strengthening Program in the Prevention of MTSS in Collegiate XC Runners

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07256808
Enrollment
26
Registered
2025-12-01
Start date
2023-09-14
Completion date
2024-02-14
Last updated
2025-12-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Medial Tibial Stress Syndrome

Brief summary

This randomized controlled trial investigated whether a 10-week heavy resistance training program reduced the incidence of medial tibial stress syndrome (MTSS) in collegiate indoor track and field athletes. Twenty-six athletes from Rowan University were randomly assigned to a treatment group (resistance training plus regular training) or a control group (regular training only). Muscle mechanical properties-including tone, stiffness, elasticity, stress relaxation time, and creep-were measured by MyotonPro device (non-invasive) at baseline, post-intervention, and at the end of the season. A 10-week observational follow-up during the indoor season included weekly MTSS symptom surveys. Differences in MTSS incidence and muscle properties were analyzed between groups.

Interventions

OTHERResistance Training

Participants performed a 10-week resistance training program, completing exercises twice daily for Weeks 1-2 and three times daily for Weeks 3-10, with 5 sessions per week for Weeks 1-7 and 6 sessions per week for Weeks 8-10. The program included exercises such as standing broad jumps, resisted ankle abduction, single-leg eccentric plantar flexion, and ankle rockers. Participants' muscle properties were assessed at the start and end of the intervention, with adherence monitored via remote video confirmation.

Sponsors

Rowan University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Collegiate athletes on the Indoor Track and Field team. * Athletes must participate in at least one of the following: * 60m-800m events (including hurdles) * jumping events (including pole vault)

Exclusion criteria

* Subjects who have a history of musculoskeletal or neurologic conditions * Who take medications that affect muscle tone * Who have a body mass index \>30.0 kg/m2 were excluded to screen to prevent adipose tissue from skewing the measurements. * Any subject with any fractures, sprains, or strains of the lower extremities were excluded. * Any subject with active MTSS, stress fracture, or other lower leg pathology symptoms at the time the initial survey was administered were excluded. * Any athlete who does not participate in the 60m-800m events (including hurdles), or who does not participate in jumping events (including pole vault) were excluded.

Design outcomes

Primary

MeasureTime frameDescription
Subjective Medial Tibial Stress Syndrome SymptomsThrough the running season -- approximately 11 weeksMedial Tibial Stress Syndrome (MTSS) Score Survey

Secondary

MeasureTime frameDescription
Myotonometry Oscillation frequencyFrom enrollment through the end of data collection -- approximately 25 weeksRepresents the intrinsic tension of the muscle in its passive state, essentially the muscle's tone.
Myotonometry dynamic stiffnessFrom enrollment through the end of data collection -- approximately 25 weeksMeasures the resistance of the tissue to deformation when subjected to an external force.
Myotonometry logarithmic decrementFrom enrollment through the end of data collection -- approximately 25 weeksIndicates the elasticity of the muscle
Myotonometry mechanical stress relaxation timeFrom enrollment through the end of data collection -- approximately 25 weeksMeasures the time it takes for the muscle to return to its original shape after being deformed.
Myotonometry creepFrom enrollment through the end of data collection -- approximately 25 weeksDescribes the gradual elongation of the muscle under constant tensile stress over time.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026